## AON: Aon plc - XLF: Financial Services

### Executive Summary

No thesis match: PEG 1.54 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($340.99)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Piper Sandler lowers Arthur J. Gallagher stock price target on deal margin concerns**
- Source: Investing.com | 20251215T140814 | Neutral | Relevance: 73%
- Piper Sandler has reduced its price target for Arthur J. Gallagher (NYSE:AJG) to $280 from $295 while maintaining an Overweight rating, citing the need for conservatism in deal margins. This adjustment precedes the company's mid-quarter investor meeting and considers AJG's premium valuation compared to peers, which could be at risk if organic growth outlooks are less optimistic. The article also mentions recent acquisitions by Arthur J. Gallagher and price target adjustments from other analysts like Wolfe Research and Truist Securities.

**2. Digital insurer Baloise builds future on DXC Assure Digital Platform | DXC Customer Stories**
- Source: DXC Technology | 20251214T180933 | Somewhat-Bullish | Relevance: 64%
- Digital insurer Baloise partnered with DXC Technology to implement the DXC Assure Digital Platform, aiming to enhance customer experience and broker engagement. This platform provides multiline functionality, personalized user experiences across multiple channels, and robust API integration, leading to a 50% increase in new business issued by brokers. The collaboration highlights a successful co-development model focused on flexibility and open IT systems for future growth.

**3. Brown & Brown (BRO): Reassessing Valuation After a Recent Share Price Pullback**
- Source: Simply Wall Street | 20251212T060746 | Neutral | Relevance: 64%
- Brown & Brown (BRO) has seen its stock price drop by approximately 23% year-to-date, despite continued double-digit revenue and earnings growth. While a narrative fair value suggests the stock is 17.1% undervalued at $93.50, other market ratios indicate caution, with the company trading at 26.8 times earnings compared to an industry average of 13.1 times. Investors are encouraged to consider both the growth narrative and potential risks, as well as build a personalized view of the company.

**4. How Wall Street Downgrades Amid Softer Insurance Pricing Will Impact Brown & Brown (BRO) Investors**
- Source: Simply Wall Street | 20251214T090817 | Neutral | Relevance: 62%
- Several Wall Street firms have downgraded Brown & Brown (BRO) due to softer property and casualty insurance pricing, despite the company reporting higher Q3 2025 revenue. These downgrades highlight how broader market trends are influencing investor perception, even as the company's Q3 revenue growth was solid, but earnings per share remained flat. The investment narrative for BRO now hinges on its ability to maintain profit growth amidst potential margin pressures from a cooling insurance market.

**5. Who Owns Marsh & McLennan? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251213T130836 | Neutral | Relevance: 61%
- This article examines the ownership structure and recent insider trading activity of Marsh & McLennan (NYSE: MMC), a global professional services firm. It highlights that large passive institutions are the primary shareholders, while hedge funds show selective accumulation and insider trades are modest, indicating stable long-term fundamentals despite recent stock volatility. The analysis suggests confidence in the company's earnings durability and pricing power.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Barclays | $379 | $420 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Barclays | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 6 ($2.72M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.6% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (-1.5%)
- Blackrock Inc.: 7.4% (-0.5%)
- Capital World Invest: 5.6% (-0.6%)
- State Street Corpora: 4.3% (+1.1%)
- Massachusetts Financ: 4.1% (-2.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +5.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.54 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 38%, margin 16%). Balance sheet: $1.1B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($2.7M in 90 days), potential headwind.

| Metric | Value |
|--------|-------|
| Market Cap | $76.3B |
| Beta | 0.83 |
| 52W Range | $323.73 - $412.97 |
| Short Interest | 1.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.54 |
| Forward P/E | 18.6 |
| Current P/E | 20.8 |
| YoY Growth | 12.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.3% to 3.3% (+5.6% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 69th percentile. MRS_5 at 3.6% confirms short-term momentum alignment. Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 57. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.34% (CS: 69) | Strong |
| RSI_14 | 57.3 | Neutral |
| MACD Histogram | 0.23 | Bullish |
| vs SMA20 | 1.018x | Above |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 0.976x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $353.79
- **Stop Loss:** $340.99 (3.6% risk)
- **Target:** $366.59 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $32,902.47
- **Portfolio %:** 32.90%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-06 (Est: $4.77)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.91 | $3.05 | +4.7% |
| 2025Q2 | $3.41 | $3.49 | +2.5% |
| 2025Q1 | $6.04 | $5.67 | -6.1% |
| 2024Q4 | $4.25 | $4.42 | +4.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*